- Reported purity
- 99.948%99.5%+
- Test date
- May 7, 2026
- Laboratory named
- Kovera Labs
Lot details
MTS400526
Market
R
Popular
45% below market
on 8 popular peptides
Catalog
42% below market
$ price level · 11 listings
Peptides
9
8 popular carried
COA coverage, in stock
2 of 8
25% of in-stock products · in-stock vendor median 54%
Cheapest on
- BPC-157▼ 60%
- SS-31▼ 54%
- Tesamorelin▼ 48%
Price check
Listed prices at retaone against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
BPC-15710 mg vial · lowest elsewhere $2/mg at Grey Axis Research▼ 60%$2.20/mgSS-3110 mg vial · lowest elsewhere $3/mg at Panda Peptides▼ 54%$2.70/mgTesamorelin10 mg vial · lowest elsewhere $5/mg at Double R Labs▼ 48%$3.90/mgSemax10 mg vial · lowest elsewhere $1.90/mg at Grey Axis Research▼ 45%$2.60/mgPT-14110 mg vial · lowest elsewhere $2.20/mg at Grey Axis Research▼ 42%$2.60/mgGlutathione1500 mg vial · lowest elsewhere $0.02/mg at Grey Axis Research▼ 41%$0.03/mg
Below the market median on 8 of 8 comparable listings, above it on 0. Typical listing: 43% below market. Showing the 6 largest differences.
Popular peptides
8 of 22 carriedFull catalog (9)
Product documentation
retaone COA coverage
Current certificates are on file for 3 of 9 tracked peptide products from retaone. The public index contains 4 documents. Reported test dates in this set run from May 7, 2026 through May 7, 2026. That coverage figure counts the full tracked catalogue for retaone, including products that are currently out of stock, so it can differ from the in-stock figure above.
- Product coverage
- 3 of 9
- Tested in past year
- 3 of 3
- Older records
- 0
- Most named lab
- Kovera Labs
33% · tracked-vendor median 54%
Based on the printed test date.
Printed date is over 18 months old.
100% of current records that name a lab.
3 current records
View COA
- Reported purity
- 99.885%99.5%+
- Test date
- May 7, 2026
- Laboratory named
- Kovera Labs
Lot details
NAD5000526
- Reported purity
- 99.939%99.5%+
- Test date
- May 7, 2026
- Laboratory named
- Kovera Labs
Lot details
TS100526
| Printed lab | Certificate | |||
|---|---|---|---|---|
| MOTS-c | Kovera Labs | May 7, 2026 | 99.948%99.5%+ | View COA |
| NAD+ | Kovera Labs | May 7, 2026 | 99.885%99.5%+ | View COA |
| Tesamorelin | Kovera Labs | May 7, 2026 | 99.939%99.5%+ | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These numbers measure document coverage only. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.